Stratos Wealth Partners’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-3,873
| Closed | -$309K | – | 1254 |
|
|
2022
Q2 | $309K | Sell |
3,873
-821
| -17% | -$65.5K | 0.01% | 920 |
|
|
2022
Q1 | $494K | Sell |
4,694
-874
| -16% | -$92K | 0.01% | 818 |
|
|
2021
Q4 | $600K | Buy |
5,568
+38
| +0.7% | +$4.1K | 0.01% | 743 |
|
|
2021
Q3 | $606K | Buy |
5,530
+159
| +3% | +$17.4K | 0.02% | 689 |
|
|
2021
Q2 | $503K | Sell |
5,371
-1,226
| -19% | -$115K | 0.01% | 770 |
|
|
2021
Q1 | $607K | Sell |
6,597
-639
| -9% | -$58.8K | 0.02% | 653 |
|
|
2020
Q4 | $529K | Sell |
7,236
-2,392
| -25% | -$175K | 0.02% | 660 |
|
|
2020
Q3 | $748K | Buy |
+9,628
| New | +$748K | 0.02% | 493 |
|
|
2018
Q4 | – | Sell |
-2,000
| Closed | -$39K | – | 2932 |
|
|
2018
Q3 | $39K | Buy |
+2,000
| New | +$39K | ﹤0.01% | 1572 |
|
|
2018
Q2 | – | Sell |
-2,750
| Closed | -$39K | – | 3016 |
|
|
2018
Q1 | $39K | Sell |
2,750
-5,300
| -66% | -$75.2K | ﹤0.01% | 1705 |
|
|
2017
Q4 | $118K | Buy |
+8,050
| New | +$118K | 0.01% | 1095 |
|